| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/11/1993 | EP0554364A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 08/11/1993 | EP0554356A1 A monoclonal antibody |
| 08/11/1993 | EP0554344A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 08/11/1993 | EP0554335A1 Corynebacteria and related organisms as vaccine vectors |
| 08/11/1993 | EP0554319A1 Antimicrobial composition |
| 08/11/1993 | EP0487594B1 A reagent for the detection of fibrinolytic activity |
| 08/11/1993 | EP0434749B1 Pharmaceutical compositions for eliciting an immunostimulant effect |
| 08/11/1993 | EP0194276B1 Production of chimeric antibodies |
| 08/11/1993 | CN1075147A A chinese isolated of a non-A, non-B hepatitis virus: compositions and methods |
| 08/10/1993 | US5235045 Viricides |
| 08/10/1993 | US5234822 Diagnosis, therapy, vaccines |
| 08/10/1993 | CA1321190C Method and product for increasing fertility in sheep |
| 08/10/1993 | CA1321143C High titer varicella zoster immune globulin for intravenous administration |
| 08/10/1993 | CA1321142C Mycoplasma hyopneumoniae antigen and uses therefor |
| 08/05/1993 | WO1993015405A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor |
| 08/05/1993 | WO1993015210A1 Monomeric and dimeric antibody-fragment fusion proteins |
| 08/05/1993 | WO1993015207A2 Hepatitis therapeutics |
| 08/05/1993 | WO1993015205A2 Synthetic haemophilus influenzae conjugate vaccine |
| 08/05/1993 | WO1993015199A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/05/1993 | WO1993015117A1 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 08/05/1993 | WO1993015111A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
| 08/05/1993 | WO1993014786A1 Composition and method to prevent conception or to cause sterility in animals |
| 08/05/1993 | WO1993014785A1 Immunotherapy for recurrent hsv infections |
| 08/05/1993 | WO1993014784A1 Vaccine against staphylococci and preparation thereof |
| 08/05/1993 | WO1993014778A1 Ex vivo gene transfer |
| 08/05/1993 | WO1993014776A1 Icam-related protein |
| 08/05/1993 | WO1993014754A1 Histamine derivatives and methods for their use as immunomodulators |
| 08/05/1993 | WO1993014750A2 Amino acids useful as inhibitors of the advanced glycosylation of proteins |
| 08/05/1993 | WO1993014744A1 Non-toxic lipid vaccine formulations |
| 08/05/1993 | WO1993014634A1 Protective effects of mutated superantigens |
| 08/05/1993 | WO1993014629A1 Gene transfer in birds by introduction of dna into muscle in ovo |
| 08/05/1993 | WO1993012755A3 Detection of alzheimer's disease and other diseases using a photoaffinity labeling method |
| 08/05/1993 | WO1993006866A3 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 08/05/1993 | CA2128896A1 Hepatitis therapeutics |
| 08/05/1993 | CA2128700A1 Carcinoma associated antigen (sk1) and monoclonal antibodies against sk1, methods of producing these antibodies and use therefor |
| 08/05/1993 | CA2128616A1 Ex vivo gene transfer |
| 08/05/1993 | CA2128516A1 Histamine derivatives and methods for their use as immunomodulators |
| 08/05/1993 | CA2128415A1 Protective effects of mutated superantigens |
| 08/05/1993 | CA2117429A1 Gene transfer in birds by introduction of dna into muscle in ovo |
| 08/05/1993 | CA2107363A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
| 08/04/1993 | EP0554064A1 Vaccine against schistosomiasis |
| 08/04/1993 | EP0553291A1 Treatment of autoimmune diseases by oral administration of autoantigens |
| 08/04/1993 | EP0553244A1 Targeted immunostimulation with bispecific reagents |
| 08/04/1993 | EP0553198A1 Regulation of immunoglobulin production by interleukin-9 |
| 08/04/1993 | EP0553117A1 Genetically engineered coccidiosis vaccine |
| 08/04/1993 | EP0553113A1 Adhesion receptors for pathogenic or opportunistic microorganisms |
| 08/04/1993 | EP0417193B1 Freeze-dried formulation for antibody products |
| 08/04/1993 | EP0253887B1 Low dosage of interferon to enhance vaccine efficiency |
| 08/04/1993 | EP0203093B1 Monoclonal antibodies against alveolar surfactant protein |
| 08/04/1993 | EP0193586B1 ANTIGENS OF $i(PLASMODIUM FALCIPARUM) |
| 08/04/1993 | CN1074844A Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 08/03/1993 | US5233024 Anti-idiotypic monoclonal antibodies for mucoid pseudomonas aeruginosa, their preparation and use |
| 08/03/1993 | US5232694 Canine corona virus vaccine |
| 08/03/1993 | US5232690 Use of zinc calcium hydroxide, lecithin and pao as an adjuvant for antigen solutions, and antigen solutions treated with an adjuvant of this type |
| 08/03/1993 | CA1320906C Interleukin-2 induced antineoplastic peptide |
| 07/29/1993 | CA2088078A1 Vaccine against schistosomiasis |
| 07/28/1993 | EP0552342A1 Method for inhibiting blood coagulant activity |
| 07/28/1993 | EP0552297A1 Hepatitis c virus antibody |
| 07/28/1993 | EP0552296A1 Mouse monoclonal antibodies |
| 07/28/1993 | EP0552256A1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 07/28/1993 | EP0552142A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 07/28/1993 | CN1074684A Thioether conjugates |
| 07/28/1993 | CA2107097A1 Icam-related protein |
| 07/27/1993 | US5231168 Malaria antigen |
| 07/27/1993 | US5231081 Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors |
| 07/27/1993 | US5231026 DNA encoding murine-human chimeric antibodies specific for antigenic epitopes of IgE present on the extracellular segment of the membrane domain of membrane-bound IgE |
| 07/27/1993 | US5231024 Hybridoma cells |
| 07/27/1993 | US5230997 Methods of detecting the presence of human herpesvirus-7 infection |
| 07/27/1993 | US5230888 Polio virus and DNA sequence codes |
| 07/27/1993 | US5230887 Autoimmune disease |
| 07/22/1993 | WO1993014406A1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 07/22/1993 | WO1993014220A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
| 07/22/1993 | WO1993014219A1 Marek's disease virus recombinant poxvirus vaccine |
| 07/22/1993 | WO1993014209A1 Vaccines based on streptokinase |
| 07/22/1993 | WO1993014208A2 Hepatitis e virus vaccine and method |
| 07/22/1993 | WO1993014207A1 Chimeric immunogens |
| 07/22/1993 | WO1993014206A2 Synthetic peptides for a rubella vaccine |
| 07/22/1993 | WO1993014204A1 Babesial antigens |
| 07/22/1993 | WO1993014202A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 07/22/1993 | WO1993014201A1 Dna encoding a human 5-ht1f receptor and uses thereof |
| 07/22/1993 | WO1993014198A1 Multifunctional surface protein of streptococci |
| 07/22/1993 | WO1993014197A1 Hypericin treatment of vaccine agents for improved immunogenicity |
| 07/22/1993 | WO1993014196A1 Preparation of mystery disease virus antigens and vaccines and antigens and vaccines produced for the prevention of this disease |
| 07/22/1993 | WO1993014195A1 Vaccine containing acemannan as an adjuvant |
| 07/22/1993 | WO1993014194A1 Recombinant swinepox virus |
| 07/22/1993 | WO1993014190A1 Feline leukemia virus vaccines |
| 07/22/1993 | WO1993014126A1 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus |
| 07/22/1993 | WO1993014116A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | WO1993013806A1 Inactivation of cytotoxic drugs |
| 07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
| 07/22/1993 | WO1993013798A1 Treatment for asthma |
| 07/22/1993 | WO1993013797A2 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera |
| 07/22/1993 | WO1993013785A1 Induced tolerance to xenografts |
| 07/22/1993 | WO1993013784A1 Platelet transfusion |
| 07/22/1993 | WO1993013775A1 Diaminopyridine compounds for the inhibition of protein glycosylation |
| 07/22/1993 | WO1993013772A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics |
| 07/22/1993 | WO1993010239A3 Hepatitis-c virus testing |
| 07/22/1993 | WO1993007262A3 Purified chitin deacetylase |
| 07/22/1993 | WO1993006852A3 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/22/1993 | WO1993002693A3 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |